Laure Buisson

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.

Journal: Blood cancer journal
Published: August 21, 2023

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.

Journal: Blood
Published: July 21, 2022

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Journal: Blood
Published: December 09, 2021

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.

Journal: Blood
Published: July 22, 2020

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.

Journal: Immunity
Published: September 25, 2019

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).

Journal: Blood
Published: November 16, 2018

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Journal: Blood advances
Published: September 07, 2018

Multiple myeloma clonal evolution in homogeneously treated patients.

Multiple myeloma clonal evolution in homogeneously treated patients.

Journal: Leukemia
Published: October 12, 2017

Expressed fusion gene landscape and its impact in multiple myeloma.

Expressed fusion gene landscape and its impact in multiple myeloma.

Journal: Nature communications
Published: September 06, 2016
Showing 1-9 of 9

Last Updated: 09/26/2026